Pomerantz LLP is investigating Syndax Pharmaceuticals and its executives for possible securities fraud following the company's announcement that its Phase 2 trial for axatilimab in idiopathic pulmonary fibrosis failed to meet its primary endpoint. This news caused Syndax's stock to drop 2.59% on October 12, 2026. The investigation aims to determine if the company engaged in unlawful business practices that harmed investors. Investors affected are encouraged to contact Pomerantz LLP to join the class action lawsuit.
Syndax Pharmaceuticals news offers context for readers. For those following the Health sector, here is Pluang's market snapshot as of Nov 11, 2026 06:11 WIB: Out of 150 priced US Health stocks, 48 rose and 100 fell. Notable movers include HIMS at USD 18.98 with a -17.26% change and 59% buy orders, WGS at USD 55.10 down 16.16% with 100% buy orders, and INO at USD 1.34 down 11.26% with 72% buy orders. Typical hold times range from 21 to 41 days.
Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...
Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...
TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...
Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...
OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...
